Company Overview - Spyre Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing advanced antibody engineering and therapeutic combinations for treating Inflammatory Bowel Disease (IBD) and other immune-mediated diseases [3]. Upcoming Events - The company will participate in the TD Cowen 45th Annual Healthcare Conference on March 4, 2025, at 3:10 PM ET, featuring a fireside chat and one-on-one meetings [1]. - Additionally, Spyre Therapeutics will attend the Jefferies Biotech on the Beach Summit on March 11, 2025, which will consist of one-on-one meetings [2]. Product Pipeline - Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23, aimed at addressing IBD and other immune-mediated diseases [3].
Spyre Therapeutics to Participate in Upcoming March Investor Conferences